Parcion Private Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Parcion Private Wealth’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.04M	Buy	12,871 +17	+0.1%	+$2.3K	0.11%	116
2026 Q1	$1.64M	Hold	12,854	–	–	0.1%	121
2025 Q4	$1.57M	Sell	12,854 -5,845	-31%	-$670K	0.1%	113
2025 Q3	$1.87M	Sell	18,699 -3,196	-15%	-$288K	0.12%	101
2025 Q2	$1.82M	Hold	21,895	–	–	0.13%	96
2025 Q1	$1.78M	Hold	21,895	–	–	0.14%	92
2024 Q4	$1.97M	Sell	21,895 -4,033	-16%	-$391K	0.15%	85
2024 Q3	$2.56M	Hold	25,928	–	–	0.21%	75
2024 Q2	$2.4M	Sell	25,928 -658	-2%	-$59K	0.22%	77
2024 Q1	$2.52M	Buy	+26,586	New	+$2.47M	0.22%	79

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Parcion Private Wealth's XBI Position: Q2 2026 in Review

Parcion Private Wealth increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.13% in Q2 2026, buying an estimated $2.3K and bringing the position to 12,871 shares worth $2.04M. The position accounts for 0.11% of the portfolio, ranked #116.

Parcion Private Wealth first reported a position in XBI in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.56M in Q3 2024. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Parcion Private Wealth held 12,871 shares of State Street SPDR S&P Biotech ETF worth $2.04M as of Q2 2026.
Parcion Private Wealth bought 17 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $2.3K.
State Street SPDR S&P Biotech ETF made up 0.11% of Parcion Private Wealth's portfolio in Q2 2026, its #116 holding.
Parcion Private Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and has held it in 10 quarters since.
Parcion Private Wealth's State Street SPDR S&P Biotech ETF position peaked at $2.56M in Q3 2024.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Parcion Private Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.